Stocks & Options
Trading Strategies
Institutional Ownership
SEC Filings TLDR
Analysis Reports
AI Tools
EN
Sign in
BIOREGENX, INC. Reports FY 2025 Financial Results
2026-04-15
SEC Filing 10-K
(0001683168-26-002975)
Please check the link below for details.
Ticker mentioned:
BRGX
Source:
Original SEC Document β